Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Cyxtera Technologies provides an integrated, secure, and resilient infrastructure platform.
Shoulder Innovations is a medical device company that develops inset glenoid fixation technology.
Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Nearfield Instruments develops and supplies metrology & inspection equipment for semiconductor manufacturing process control.
Starling Bank is a bank that offers personal, joint, and business accounts.
Oddity is a consumer-tech company that builds and scales digital-first brands.
ASAPP is the agentic Customer Experience Platform (CXP) purpose-built for enterprise customer service.
Rush Street Interactive offers online casino and sports betting in the U.S.
Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.
Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.
ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.
P3 Health Partners is a patient-centered, physician-led and population health-focused healthcare company.
Osmoses engages in decarbonizing gas separations to eliminate one gigaton of carbon emissions per year.
Smart is a savings and investments technology platform provider.
Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.
High-conductance, large-area flexible circuits for the clean power revolution.
Tumelo is an impact-focused financial technology firm with the mission of giving every investor a voice.
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.
Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
T1 Energy is a solar and battery manufacturing company for commercial and industrial sectors.
ABL Space Systems specializes in building rockets to launch satellites.
Fidelity has invested in 257 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Fidelity's top investment sectors include Biotechnology, Health Care, Information Technology, Financial Services, Therapeutics. The firm invests across 51 different industry categories.
Among tracked funding rounds, Revolution Medicines received $1.5B in a Post-IPO Equity round. Fidelity's total known invested capital is $23.8B.
Fidelity's average investment size is $138.5M across its portfolio of 257 companies.
Recent Fidelity portfolio additions include Cyxtera Technologies, Shoulder Innovations, Nuvation Bio, Absci, Nearfield Instruments. These companies were founded in 2020 or later.